AHA today urged the Drug Enforcement Administration to include drug shortages as a factor when setting and adjusting aggregate and individual manufacturers’ production quotas for controlled substances. Commenting on the agency’s proposed rule on controlled substances quotas, AHA also recommended that DEA routinely consult with the Food and Drug Administration’s drug shortage staff when establishing and adjusting quotas. “As the DEA is well aware, hospitals and health systems continue to experience critical shortages of a number of injectable opioid medications, such as morphine, hydromorphone and fentanyl, due to both a slowdown in production and a component problem at a major manufacturing facility,” AHA wrote. “These intravenous opioids are widely used and essential to appropriate patient care in hospitals and in other practice settings for the treatment of acute and chronic pain, and for sedation purposes.” AHA also joined with the American Society of Health-System Pharmacists, America’s Health Insurance Plans, American Society of Clinical Oncology, American Society of Anesthesiologists, and Institute for Safe Medication Practices in a letter to DEA requesting similar changes to the proposed rule.

Related News Articles

Headline
The Department of Health and Human Services this week awarded $487 million in fiscal year 2019 grants to help states and territories increase access to…
Headline
The three medications approved by the Food and Drug Administration to treat opioid use disorder — methadone, buprenorphine and extended-release naltrexone —…
Headline
In a study of Blue Cross and Blue Shield enrollees reported last week in the New England Journal of Medicine, initial opioid prescriptions declined 54 percent…
Headline
The House Energy and Commerce Health Subcommittee today held a hearing on the president’s fiscal year 2020 budget request for the Department of Health and…
Headline
Eligible organizations can apply through May 6 for up to $1 million each for a three-year period to expand opioid and other substance use disorder services in…
Insights and Analysis
Birmingham VA Medical Center’s weekly, 90-minute shared medical appointments help veterans address opioid reliance.